Skip to main content
. 2021 Dec 30;16:3551–3559. doi: 10.2147/COPD.S347948

Table 3.

Comparison of Treatment Between Eosinopenia and Non-eosinopenia Groups

Variables Eosinopenia (n=41) Non-Eosinopenia (n=18) p
Length of hospital stay, days, median (IQR) 8.00 (6.00, 15.00) 8.00 (5.25, 11.00) 0.437
Hospital cost, ¥, median (IQR) 20,598.00 (11,357.00, 55,709.50) 14,295.50 (7748.00, 19,584.00) 0.043
In-hospital treatment
 Duration of antibiotic use, days, median (IQR) 7.00 (5.00, 13.0) 6.50 (3.75, 9.25) 0.097
 Non-invasive ventilation, n (%) 13(31.7%) 4(22.2%) 0.459
 Mechanical ventilation, n (%) 14(34.1%) 2(11.1%) 0.067
Corticosteroids use
 Systemic corticosteroids use, n (%) 30(73.2%) 9(50.0%) 0.083
 Total dose of systemic corticosteroids, mg, median (IQR)# 160.00 (0.00, 240.00) 40.00 (0.00, 120.00) 0.019
 Daily dose of systemic corticosteroids, mg/day, median (IQR)# 40.00 (0.00, 40.00) 18.40 (0.00, 40.00) 0.028
 Total dose of ICS, mg, median (IQR)* 42.00 (22.50, 64.00) 36.00 (20.25, 64.00) 0.824
 Daily dose of ICS, mg/day, median (IQR)* 6.00 (3.23, 6.00) 6.00 (3.00, 6.00) 0.412

Notes: #Reported in methylprednisolone equivalent. *Reported in BDP (budesonide equivalent).

Abbreviations: IQR, interquartile range; ¥, Chinese Yuan; ICS, inhaled corticosteroids.